nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Headache—Pentoxifylline—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Disopyramide—Feeling abnormal—Captopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Disopyramide—Chest pain—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Disopyramide—Vision blurred—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Disopyramide—Asthenia—Mometasone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Disopyramide—Hypotension—Azathioprine—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Disopyramide—Cardiac arrest—Prednisone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Disopyramide—Discomfort—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Disopyramide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Disopyramide—Pruritus—Mometasone—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Disopyramide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Disopyramide—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Disopyramide—Skin disorder—Leflunomide—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Disopyramide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Disopyramide—Angioedema—Lisinopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Disopyramide—Confusional state—Mycophenolic acid—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Disopyramide—Body temperature increased—Captopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Disopyramide—Oedema—Mycophenolic acid—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Disopyramide—Anorexia—Leflunomide—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Disopyramide—Nausea—Pentoxifylline—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Disopyramide—Malaise—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Disopyramide—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Disopyramide—Vertigo—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Disopyramide—Diarrhoea—Mometasone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Disopyramide—Hypokalaemia—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Disopyramide—Syncope—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Disopyramide—Shock—Mycophenolic acid—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Disopyramide—Hypotension—Leflunomide—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Disopyramide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Disopyramide—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Disopyramide—Loss of consciousness—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Disopyramide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Disopyramide—Muscular weakness—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Disopyramide—Anorexia—Mycophenolic acid—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Disopyramide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Disopyramide—Tension—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Disopyramide—Insomnia—Leflunomide—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Disopyramide—Abdominal distension—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Disopyramide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Disopyramide—Paraesthesia—Leflunomide—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Disopyramide—Chest pain—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Disopyramide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Disopyramide—Dyspnoea—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Disopyramide—Hypotension—Mycophenolic acid—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Disopyramide—Discomfort—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Disopyramide—Dyspepsia—Leflunomide—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Disopyramide—Vomiting—Mometasone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Disopyramide—Dry mouth—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Disopyramide—Sweating increased—Prednisone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Disopyramide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Disopyramide—Rash—Mometasone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Disopyramide—Asthenia—Captopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Disopyramide—Dermatitis—Mometasone—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Disopyramide—Decreased appetite—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Disopyramide—Confusional state—Lisinopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Disopyramide—Headache—Mometasone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Disopyramide—Insomnia—Mycophenolic acid—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Disopyramide—Fatigue—Leflunomide—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Disopyramide—Oedema—Lisinopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Disopyramide—Pruritus—Captopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Disopyramide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Disopyramide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Disopyramide—Constipation—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Disopyramide—Pain—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Disopyramide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Disopyramide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Disopyramide—Shock—Lisinopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Disopyramide—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Disopyramide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Disopyramide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Disopyramide—Neutropenia—Prednisone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Disopyramide—Body temperature increased—Azathioprine—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Disopyramide—Skin disorder—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Disopyramide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Disopyramide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Disopyramide—Diarrhoea—Captopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Disopyramide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Disopyramide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Disopyramide—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Disopyramide—Erectile dysfunction—Prednisone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Disopyramide—Feeling abnormal—Leflunomide—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Disopyramide—Fatigue—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Disopyramide—Nausea—Mometasone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Disopyramide—Anorexia—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Disopyramide—Weight increased—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Disopyramide—Pain—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Disopyramide—Constipation—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Disopyramide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Disopyramide—Hypotension—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Disopyramide—Dizziness—Captopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Disopyramide—Depression—Prednisone—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Disopyramide—Urticaria—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Disopyramide—Body temperature increased—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Disopyramide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Disopyramide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Disopyramide—Insomnia—Lisinopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Disopyramide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Disopyramide—Paraesthesia—Lisinopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Disopyramide—Vomiting—Captopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Disopyramide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Disopyramide—Dyspnoea—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Disopyramide—Rash—Captopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Disopyramide—Dermatitis—Captopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Disopyramide—Somnolence—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Disopyramide—Headache—Captopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Disopyramide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Disopyramide—Dyspepsia—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Disopyramide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Disopyramide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Disopyramide—Decreased appetite—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Disopyramide—Fatigue—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Disopyramide—Shock—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Disopyramide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Disopyramide—Pain—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Disopyramide—Constipation—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Disopyramide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Disopyramide—Bradycardia—Prednisone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Disopyramide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Disopyramide—Diarrhoea—Azathioprine—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Disopyramide—Nausea—Captopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Disopyramide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Disopyramide—Asthenia—Leflunomide—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Disopyramide—Feeling abnormal—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Disopyramide—Pruritus—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Disopyramide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Disopyramide—Dizziness—Azathioprine—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Disopyramide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Disopyramide—Diarrhoea—Leflunomide—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Disopyramide—Urticaria—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Disopyramide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Disopyramide—Body temperature increased—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Disopyramide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Disopyramide—Pruritus—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Disopyramide—Vomiting—Azathioprine—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Disopyramide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Disopyramide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Disopyramide—Rash—Azathioprine—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Disopyramide—Dermatitis—Azathioprine—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Disopyramide—Depression—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Disopyramide—Headache—Azathioprine—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Disopyramide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Disopyramide—Dizziness—Leflunomide—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Disopyramide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Disopyramide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Disopyramide—Pain—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Disopyramide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Disopyramide—Arrhythmia—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Disopyramide—Vomiting—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Disopyramide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Disopyramide—Rash—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Disopyramide—Dermatitis—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Disopyramide—Nausea—Azathioprine—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Disopyramide—Headache—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Disopyramide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Disopyramide—Asthenia—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Disopyramide—Pruritus—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Disopyramide—Vomiting—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Disopyramide—Rash—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Disopyramide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Disopyramide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Disopyramide—Headache—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Disopyramide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Disopyramide—Nausea—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Disopyramide—Vision blurred—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Disopyramide—Diarrhoea—Lisinopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Disopyramide—Angioedema—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Disopyramide—Dizziness—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Disopyramide—Nausea—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Disopyramide—Malaise—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Disopyramide—Vertigo—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Disopyramide—Syncope—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisone—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Disopyramide—Vomiting—Lisinopril—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Disopyramide—Rash—Lisinopril—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Disopyramide—Dermatitis—Lisinopril—systemic scleroderma	0.000974	0.000974	CcSEcCtD
Disopyramide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Disopyramide—Headache—Lisinopril—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Disopyramide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Disopyramide—Discomfort—Prednisone—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Disopyramide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Disopyramide—Nausea—Lisinopril—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Disopyramide—Oedema—Prednisone—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Disopyramide—Shock—Prednisone—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Disopyramide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000896	0.000896	CcSEcCtD
Disopyramide—Skin disorder—Prednisone—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Disopyramide—Anorexia—Prednisone—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000872	0.000872	CcSEcCtD
Disopyramide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Disopyramide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Disopyramide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Disopyramide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Disopyramide—Malaise—Methotrexate—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Disopyramide—Insomnia—Prednisone—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Disopyramide—Paraesthesia—Prednisone—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Disopyramide—Dyspepsia—Prednisone—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Disopyramide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000804	0.000804	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Disopyramide—Decreased appetite—Prednisone—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Disopyramide—Fatigue—Prednisone—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Disopyramide—Constipation—Prednisone—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisone—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000742	0.000742	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Disopyramide—Urticaria—Prednisone—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Disopyramide—Body temperature increased—Prednisone—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Disopyramide—Asthenia—Prednisone—systemic scleroderma	0.000659	0.000659	CcSEcCtD
Disopyramide—Pain—Methotrexate—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Disopyramide—Pruritus—Prednisone—systemic scleroderma	0.000649	0.000649	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Disopyramide—Diarrhoea—Prednisone—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Disopyramide—Dizziness—Prednisone—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Disopyramide—Vomiting—Prednisone—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Disopyramide—Rash—Prednisone—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Disopyramide—Dermatitis—Prednisone—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Disopyramide—Headache—Prednisone—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Disopyramide—Nausea—Prednisone—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Disopyramide—Rash—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Disopyramide—Headache—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Disopyramide—Nausea—Methotrexate—systemic scleroderma	0.000456	0.000456	CcSEcCtD
